Active Wnt5A-V5 Citations (3)
Originally described in: Disulfide Bond Requirements for Active Wnt Ligands.MacDonald BT, Hien A, Zhang X, Iranloye O, Virshup DM, Waterman ML, He X J Biol Chem. 2014 May 19. pii: jbc.M114.575027. PubMed Journal
Articles Citing Active Wnt5A-V5
Articles |
---|
Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-beta and WNT7B in Human Lung Fibroblasts. Newman DR, Sills WS, Hanrahan K, Ziegler A, Tidd KM, Cook E, Sannes PL. J Histochem Cytochem. 2016 Feb;64(2):99-111. doi: 10.1369/0022155415617988. Epub 2015 Nov 4. PubMed |
Sfrp3 modulates stromal-epithelial crosstalk during mammary gland development by regulating Wnt levels. Bernascone I, Gonzalez T, Barea MD, Carabana C, Hachimi M, Bosch-Fortea M, Santamaria S, Martin R, Tarnick J, Garcia-Sanz JA, Martin-Belmonte F. Nat Commun. 2019 Jun 6;10(1):2481. doi: 10.1038/s41467-019-10509-1. PubMed |
Activation of beta-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer. Patel R, Brzezinska EA, Repiscak P, Ahmad I, Mui E, Gao M, Blomme A, Harle V, Tan EH, Malviya G, Mrowinska A, Loveridge CJ, Rushworth LK, Edwards J, Ntala C, Nixon C, Hedley A, Mackay G, Tardito S, Sansom OJ, Leung HY. Cancer Res. 2020 Feb 1;80(3):576-590. doi: 10.1158/0008-5472.CAN-19-1684. Epub 2019 Nov 12. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.